QuickDoc.

Medical guidelines and references.

QuickDoc is targeted for medical professionals only. It is not intended to replace clinical experience and judgement.
Unless explicitly stated, copyright of all material in this website remains that of QuickDoc.

Atrial FibrillationCardiology

Atrial Fibrillation diagnosis & Management

Updated: 1st May 2024

Diagnosis

  • Palpate carotid for more reliable measure of pulse.
  • Suspect paroxysmal AF if symptoms are episodic and last less than 48 hours
  • Absence of irregular pulse makes AF unlikely. Its presence does not reliably indicate AF.
  • ECG in AF has – no P-wave, a chaotic baseline and an irregular ventricular rate
  • Rate is usually 160-180 BPM, but can be lower in typically in asymptomatic patients
  • If paroxysmal AF suspected and not found on ECG
    • Arrange ambulatory ECG
    • 24 hour ECG if symptoms < 24h apart, or event recorder ECG/7 Day Holter if > 24h apart

Management

  • Onset in last 48h
    • If haemodynamic instability (Pulse > 150BPM) and/or Low BP (systolic < 90) or LOC, severe dizziness, chest pains or SOB -> A&E for electrical cardioversion
    • Else – consider management in primary care if appropriate or refer to acute medical unit for immediate cardioversion
      • if has suspected decompensated HF, seek specialist advice on use of BB and avoid CCB.
      • Most people with symptomatic acute onset AF are initially managed in secondary care.
  • For others (including paroxysmal AF)
    • Admit if – haemodynamic instability, or other serious associated condition, e.g. CVA, PE, pneumonia, thyrotoxicosis, severe HF
    • Else – Screen for causes of AF and manage or refer as appropriate
      • Cardiac – HTN, Valve disease, HF, IHD
      • Respiratory – LRTI, Lung cancer
      • Systemic causes – Alcohol, hyperthyroidism, Electrolyte imbalance (U&E, calcium and magnesium), infection, DM
    • Cardiology referral needed if
      • A pre-excitation syndrome e.g. WPW syndrome
      • Valve disease associated with AF
      • HF suspected
      • For consideration of pharmacological or electrical rhythm control (Cardioversion)
        • AF has reversible cause – e.g. LRTI
        • HF caused or worsened by AF
    • Primary care management
      • Assess stroke risk using CHA2DS2VASc assessment tool
      • Assess bleeding risk using ORBIT bleeding risk tool 
      • If anticoagulation necessary
        • Offer DOAC
          • Apixaban, Rivaroxaban, Dabigatran and Edoxaban are all suitable
            • Apixaban and Rivaroxaban are reversed by Andexanet alfa and Dabigatran is reversed by Idarucizumab. Edoxaban has no reversing agent.
            • Do not withhold solely because of age or falls risk
        • Warfarin if DOAC not suitable
        • If anticoagulation is contraindicated – consider combination Aspirin and Clopidogrel
      • Rate control
        • 1st line – BB (other than sotalol) or CCB (Diltiazem or verapamil note avoid in HF with reduced EF)
        • 2nd line – Digoxin (for non-paroxysmal AF if they do little/no exercise or others rate limiting drugs ruled out)
        • Arrange follow up in 1 week
          • Aim 60-80 BMP at rest, and 90-115 at moderate exercise
            • Titrate up to maximum dosage if needed to control HR and/or BP
            • If still poorly controlled – consider combination with any two of BB, digoxin or Diltazem*
              • * Specialist advice needed for BB and Diltazem combination (risk bradycardia, AV block, asystole or sudden death)
          • Consider referral for cardioversion if symptoms continue or rate control fails – to see specialist within 4 weeks